BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22419664)

  • 21. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.
    Carloni V; Luong TV; Rombouts K
    Liver Int; 2014 Jul; 34(6):834-43. PubMed ID: 24397349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The glypican 3 hepatocellular carcinoma marker regulates human hepatic stellate cells via Hedgehog signaling.
    Magistri P; Leonard SY; Tang CM; Chan JC; Lee TE; Sicklick JK
    J Surg Res; 2014 Apr; 187(2):377-85. PubMed ID: 24439425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice.
    Zhao W; Zhang L; Yin Z; Su W; Ren G; Zhou C; You J; Fan J; Wang X
    Int J Cancer; 2011 Dec; 129(11):2651-61. PubMed ID: 21213212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia Enhances Tumor-Stroma Crosstalk that Drives the Progression of Hepatocellular Carcinoma.
    Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
    Dig Dis Sci; 2016 Sep; 61(9):2568-77. PubMed ID: 27074919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of differential gene expression in rat hepatic stellate cells activated by culture or hepatocellular carcinoma cell induction].
    Xia YH; Song ZJ; Chen RX; Ye SL; Sun RX; Xue Q
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):164-9. PubMed ID: 19615251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
    Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
    J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated N-methyltransferase expression induced by hepatic stellate cells contributes to the metastasis of hepatocellular carcinoma via regulation of the CD44v3 isoform.
    Li J; You S; Zhang S; Hu Q; Wang F; Chi X; Zhao W; Xie C; Zhang C; Yu Y; Liu J; Zhao Y; Liu P; Zhang Y; Wei X; Li Q; Wang X; Yin Z
    Mol Oncol; 2019 Sep; 13(9):1993-2009. PubMed ID: 31294922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo.
    Mußbach F; Ungefroren H; Günther B; Katenkamp K; Henklein P; Westermann M; Settmacher U; Lenk L; Sebens S; Müller JP; Böhmer FD; Kaufmann R
    Mol Cancer; 2016 Jul; 15(1):54. PubMed ID: 27473374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Senescent hepatic stellate cells caused by deoxycholic acid modulates malignant behavior of hepatocellular carcinoma.
    Nguyen PT; Kanno K; Pham QT; Kikuchi Y; Kakimoto M; Kobayashi T; Otani Y; Kishikawa N; Miyauchi M; Arihiro K; Ito M; Tazuma S
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3255-3268. PubMed ID: 32870388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herbal compound "Songyou Yin" attenuates hepatoma cell invasiveness and metastasis through downregulation of cytokines secreted by activated hepatic stellate cells.
    Jia QA; Wang ZM; Ren ZG; Bu Y; Xie XY; Wang YH; Zhang L; Zhang QB; Xue TC; Deng LF; Tang ZY
    BMC Complement Altern Med; 2013 Apr; 13():89. PubMed ID: 23622143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma.
    Seitz T; Freese K; Dietrich P; Thasler WE; Bosserhoff A; Hellerbrand C
    Sci Rep; 2020 Mar; 10(1):4546. PubMed ID: 32161315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
    Xie YX; Liao R; Pan L; Du CY
    Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Periostin deficiency reduces diethylnitrosamine-induced liver cancer in mice by decreasing hepatic stellate cell activation and cancer cell proliferation.
    Xiao H; Zhang Y; Li Z; Liu B; Cui D; Liu F; Chen D; Liu Y; Ouyang G
    J Pathol; 2021 Oct; 255(2):212-223. PubMed ID: 34228359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma.
    Ruan Q; Wang H; Burke LJ; Bridle KR; Li X; Zhao CX; Crawford DHG; Roberts MS; Liang X
    Int J Cancer; 2020 Sep; 147(6):1519-1527. PubMed ID: 32010970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer Stem Cell and Hepatic Stellate Cells in Hepatocellular Carcinoma.
    Quiroz Reyes AG; Lozano Sepulveda SA; Martinez-Acuña N; Islas JF; Gonzalez PD; Heredia Torres TG; Perez JR; Garza Treviño EN
    Technol Cancer Res Treat; 2023; 22():15330338231163677. PubMed ID: 36938618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway.
    Xia Y; Zhen L; Li H; Wang S; Chen S; Wang C; Yang X
    Cell Death Dis; 2021 Mar; 12(4):326. PubMed ID: 33771969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma.
    Liao R; Wu H; Yi Y; Wang JX; Cai XY; He HW; Cheng YF; Zhou J; Fan J; Sun J; Qiu SJ
    J Exp Clin Cancer Res; 2013 Apr; 32(1):22. PubMed ID: 23601182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma.
    Amann T; Bataille F; Spruss T; Mühlbauer M; Gäbele E; Schölmerich J; Kiefer P; Bosserhoff AK; Hellerbrand C
    Cancer Sci; 2009 Apr; 100(4):646-53. PubMed ID: 19175606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic stellate cells limit hepatocellular carcinoma progression through the orphan receptor endosialin.
    Mogler C; König C; Wieland M; Runge A; Besemfelder E; Komljenovic D; Longerich T; Schirmacher P; Augustin HG
    EMBO Mol Med; 2017 Jun; 9(6):741-749. PubMed ID: 28373218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatty Acid Binding Protein 4 (FABP4) Overexpression in Intratumoral Hepatic Stellate Cells within Hepatocellular Carcinoma with Metabolic Risk Factors.
    Chiyonobu N; Shimada S; Akiyama Y; Mogushi K; Itoh M; Akahoshi K; Matsumura S; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Arii S; Suganami T; Yamaoka S; Ogawa Y; Tanabe M; Tanaka S
    Am J Pathol; 2018 May; 188(5):1213-1224. PubMed ID: 29454748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.